MENU
Nektar Therapeutics (NKTR) Ownership - Who owns Nektar Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
206.17M
P/E Ratio
N/A
Total Cash
271.24M
Projected Growth
N/A
Total Debt
112.1M
Revenue
93.16M
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
1.47
Total Debt/Equity
N/A
Revenue/Share
0.47 USD as % of share price
Fundamentals
NKTR
Capitalization
206M
P/E Ratio
N/A
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
271M
Total Cash/Share
1.47
Total Debt
112M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.47%
Revenue
93.2M
ROE
N/A
Book Value
79.7M
P/B Ratio
2.59
Cash Flow
N/A
Earnings
-0.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
5.15
Current Revenue Per Employee
171452.56
Dividends Per Share - Security
N/A
EBITDA
-146.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
58.53
Revenue To Assets
-42.28
Shares Held By Institutions
182M
Shares Outstanding - Current
184M
Total Liabilities
264M
Total Volume MTD
N/A
Value
N/A
Gain YTD
100.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of inhalation drug delivery systems
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com